Quantcast

US IPO Week Ahead: Just 2 small IPOs during election week


Shutterstock photo

The IPO market will see just two small deals raise less than $100 million during the week of US midterm elections. However, the lack of activity is more attributable to market volatility than the elections - 8 IPOs raised $1.7 billion in the first week of November 2014. In addition, new filings have slowed down.

Four IPOs become eligible to launch their offerings on Monday: software unicorn Qualtrics ( XM ), pain biotech  Centrexion ( CNTX ), government service contractor  Caliburn International ( CLBR ), and small medical device maker  Vapotherm (VAPO).

U.S. IPO Calendar
Issuer
Business
Deal Size
Market Cap
Price Range
Shares Filed
Top
Bookrunners
CNFinance Holdings (CNF)
Guangzhou, China
$52M
$604M
$7.50 - $8.50
6,500,000
Roth Cap.
Shenwan Hongyuan
Leading provider of home equity loans in China.
Alzheon (ALZH)
Framingham, MA
$30M
$82M
$4 - $6
6,000,000
ThinkEquity
HC Wainwright
Phase 3 biotech developing small molecule therapies for Alzheimer's disease.


Sign up for a free trial of our premium platform, IPO Pro . Follow us on Twitter ( @IPOtweet ) and register for our updates on the IPO market.

CNFinance Holdings (CNF), a leading provider of home equity loans in China, plans to raise $52 million by offering 6.5 million ADSs at a price range of $7.50 to $8.50. Outside investors have covered the entire deal, including the green shoe. At the midpoint of the proposed range, CNFinance would command a fully diluted market value of $604 million. The founder-led company was formed in 1999 and booked $335 million in sales for the 12 months ended June 30, 2018. It plans to list on the NYSE under the symbol CNF. Roth Capital and Shenwan Hongyuan Securities are the joint bookrunners on the deal. It originally filed in June with a proposed deal size of $200 million and J.P. Morgan as the lead manager.

Alzheon (ALZH), a Phase 3 biotech developing small molecule therapies for Alzheimer's disease, plans to raise $30 million by offering 6.0 million shares at a price range of $4.00 to $6.00. In the previous week, Alzheon attempted to offer 2.5 million shares at a range of $13.00 to $15.00. At the $5.00 midpoint, Alzheon would command a market value of $82 million, less than half the size of the previous attempt. The Framingham, MA-based company was founded in 2013 and plans to list on the Nasdaq under the symbol ALZH. ThinkEquity and H.C. Wainwright are the joint bookrunners on the deal.

Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.

IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/1/18, the Renaissance IPO Index was down 4.0% year-to-date, while the S&P 500 had a gain of 4.1%. Renaissance Capital's IPO ETF ( IPO ) tracks the index, and top ETF holdings include VICI Properties (VICI) and  Spotify (SPOT). The Renaissance International IPO Index was down 16.8% year-to-date, while the ACWX was down 9.8%. Renaissance Capital's International IPO ETF ( IPOS ) tracks the index, and top ETF holdings include Siemens Healthineers  and innogy .

The article US IPO Week Ahead: Just 2 small IPOs during election week originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs
Referenced Symbols: IPO , IPOS , XM , CNTX , CLBR



More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs










Research Brokers before you trade

Want to trade FX?